Notice of a Safety Symposium Sponsored by the NIH Recombinant DNA Advisory Committee (RAC) and the Intragovernmental Select Agent and Toxin Technical Advisory Committee (ISATTAC), 67191 [E8-26886]

Download as PDF Federal Register / Vol. 73, No. 220 / Thursday, November 13, 2008 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Background information may be obtained by contacting NIH OBA by e-mail oba@od.nih.gov. National Institutes of Health, Office of the Director, Office of Biotechnology Activities Dated: November 5, 2008. Amy P. Patterson, Director, Office of Biotechnology Activities. [FR Doc. E8–26886 Filed 11–12–08; 8:45 am] Notice of a Safety Symposium Sponsored by the NIH Recombinant DNA Advisory Committee (RAC) and the Intragovernmental Select Agent and Toxin Technical Advisory Committee (ISATTAC) BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY mstockstill on PROD1PC66 with NOTICES There will be a safety symposium entitled ‘‘Public Health and Biosafety Practices for Research with 1918 H1N1 Influenza Virus’’ on December 2, 2008 co-sponsored by the RAC, a federal advisory committee to the NIH Director and the ISATTAC, an intragovernmental committee that advises on Select Agent issues including restricted experiments. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the contact person listed below in advance of the meeting. For further information concerning this meeting contact Ms. Lisa A. Parker, Advisory Committee Coordinator, Office of Biotechnology Activities, Office of the Director, National Institutes of Health, 6705 Rockledge Drive, Room 750, Bethesda, MD 20892–7985, 301–496– 9838, parkerla@od.nih.gov. Name of Committee: Recombinant DNA Advisory Committee. Date: December 2, 2008. Time: 8 a.m. to 6 p.m. Agenda: The safety symposium will bring together experts to provide their perspectives on the safety, efficacy, and advisability of pre-exposure antiviral prophylaxis for researchers working with the reconstructed pandemic 1918 H1N1 Influenza Virus and how the presence or absence of pre-exposure prophylaxis should be factored into a determination of the appropriate biocontainment level for work with the 1918 H1N1 Influenza Virus. Please check the meeting agenda at http:www4.od.nih.gov/ oba/RAC/meeting.htm for more information. Place: Fishers Lane Conference Center, 5635 Fishers Lane, Terrace Level, Rockville, MD 20892. Contact Person: Lisa A. Parker, Advisory Committee Coordinator, Office of Science Policy, Office of Biotechnology Activities, National Institutes of Health, 6705 Rockledge Drive, Suite 750–A1, Bethesda, MD 20892, 301–496–9838, parkerla@mail.nih.gov. Any interested person may file written comments with the panel by forwarding the statement to the contact person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. VerDate Aug<31>2005 17:13 Nov 12, 2008 Jkt 217001 U.S. Citizenship and Immigration Services Agency Information Collection Activities: Form I–566, Extension of a Currently Approved Information Collection; Comment Request 30-Day Notice of Information Collection Under Review: Form I–566, Interagency Record of Individual Requesting Change/Adjustment To or From A or G Status or Requesting A, G, or NATO Dependent Employment Authorization; OMB Control Number 1615–0027. ACTION: The Department of Homeland Security, U.S. Citizenship and Immigration Services (USCIS) has submitted the following information collection request to the Office of Management and Budget (OMB) for review and clearance in accordance with the Paperwork Reduction Act of 1995. The information collection was previously published in the Federal Register on August 15, 2008, at 73 FR 47961, allowing for a 60-day public comment period. USCIS did not receive any comments for this information collection. The purpose of this notice is to allow an additional 30 days for public comments. Comments are encouraged and will be accepted until December 15, 2008. This process is conducted in accordance with 5 CFR 1320.10. Written comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, should be directed to the Department of Homeland Security (DHS), and to the Office of Information and Regulatory Affairs, Office of Management and Budget (OMB), USCIS Desk Officer. Comments may be submitted to: USCIS, Chief, Regulatory Management Division, Clearance Office, 111 Massachusetts Avenue, Suite 3008, Washington, DC 20529. Comments may also be submitted to DHS via facsimile to 202–272–8352 or via e-mail at rfs.regs@dhs.gov, and to the OMB USCIS Desk Officer via facsimile at 202–395– PO 00000 Frm 00074 Fmt 4703 Sfmt 4703 67191 6974 or via e-mail at oira_submission@omb.eop.gov. When submitting comments by e-mail please make sure to add OMB Control Number 1615–0027 in the subject box. Written comments and suggestions from the public and affected agencies should address one or more of the following four points: (1) Evaluate whether the collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (2) Evaluate the accuracy of the agency’s estimate of the burden of the collection of information, including the validity of the methodology and assumptions used; (3) Enhance the quality, utility, and clarity of the information to be collected; and (4) Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques, or other forms of information technology, e.g., permitting electronic submission of responses. Overview of This Information Collection (1) Type of Information Collection: Extension of an existing information collection. (2) Title of the Form/Collection: Interagency Record of Individual Requesting Change/Adjustment To or From A or G Status or Requesting A, G, or NATO Dependent Employment. (3) Agency form number, if any, and the applicable component of the Department of Homeland Security sponsoring the collection: Form I–566. U.S. Citizenship and Immigration Services. (4) Affected public who will be asked or required to respond, as well as a brief abstract: Primary: Individuals and households. This information collection facilitates processing of applications for benefits filed by dependents of diplomats, international organizations, and NATO personnel by U.S. Citizenship and Immigration Services, and the Department of State. (5) An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: 5,800 responses at 15 minutes (.250 hours) per response. (6) An estimate of the total public burden (in hours) associated with the collection: 1,450 annual burden hours. If you have additional comments, suggestions, or need a copy of the information collection instrument, E:\FR\FM\13NON1.SGM 13NON1

Agencies

[Federal Register Volume 73, Number 220 (Thursday, November 13, 2008)]
[Notices]
[Page 67191]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-26886]



[[Page 67191]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health, Office of the Director, Office of 
Biotechnology Activities


Notice of a Safety Symposium Sponsored by the NIH Recombinant DNA 
Advisory Committee (RAC) and the Intragovernmental Select Agent and 
Toxin Technical Advisory Committee (ISATTAC)

    There will be a safety symposium entitled ``Public Health and 
Biosafety Practices for Research with 1918 H1N1 Influenza Virus'' on 
December 2, 2008 co-sponsored by the RAC, a federal advisory committee 
to the NIH Director and the ISATTAC, an intragovernmental committee 
that advises on Select Agent issues including restricted experiments. 
The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the contact person listed below in 
advance of the meeting. For further information concerning this meeting 
contact Ms. Lisa A. Parker, Advisory Committee Coordinator, Office of 
Biotechnology Activities, Office of the Director, National Institutes 
of Health, 6705 Rockledge Drive, Room 750, Bethesda, MD 20892-7985, 
301-496-9838, parkerla@od.nih.gov.

    Name of Committee: Recombinant DNA Advisory Committee.
    Date: December 2, 2008.
    Time: 8 a.m. to 6 p.m.
    Agenda: The safety symposium will bring together experts to 
provide their perspectives on the safety, efficacy, and advisability 
of pre-exposure antiviral prophylaxis for researchers working with 
the reconstructed pandemic 1918 H1N1 Influenza Virus and how the 
presence or absence of pre-exposure prophylaxis should be factored 
into a determination of the appropriate biocontainment level for 
work with the 1918 H1N1 Influenza Virus. Please check the meeting 
agenda at http:www4.od.nih.gov/oba/RAC/meeting.htm for more 
information.
    Place: Fishers Lane Conference Center, 5635 Fishers Lane, 
Terrace Level, Rockville, MD 20892.
    Contact Person: Lisa A. Parker, Advisory Committee Coordinator, 
Office of Science Policy, Office of Biotechnology Activities, 
National Institutes of Health, 6705 Rockledge Drive, Suite 750-A1, 
Bethesda, MD 20892, 301-496-9838, parkerla@mail.nih.gov.
    Any interested person may file written comments with the panel 
by forwarding the statement to the contact person listed on this 
notice. The statement should include the name, address, telephone 
number and when applicable, the business or professional affiliation 
of the interested person. Background information may be obtained by 
contacting NIH OBA by e-mail oba@od.nih.gov.

    Dated: November 5, 2008.
Amy P. Patterson,
Director, Office of Biotechnology Activities.
[FR Doc. E8-26886 Filed 11-12-08; 8:45 am]
BILLING CODE 4140-01-P